Nakamura M, Arai Y, Hirabayashi S, Kondo T, et al. Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation. Br J Haematol 2021;194:403-413.
PMID: 34159580